Danaher Correction Until Early Dec Before Extension of Rally Danaher is a strong stock. It has made employees millionaires for decades. I happened to open the chart today and saw it is in a fairly steep correction as of early November. This is an exciting opportunity to buy the dip in my opinion.
I will be looking to enter longs at the market resistance level around $205. I would expect an ABC zig zag corrective pattern before resumption of the rally. This is extremely speculative so trade at your own risk.
DHR trade ideas
DHR:NYSE - DANAHER CORP - Medical equipment and research toolsDanaher is another nice steady runner. Up around 85% since its March lows, it is currently going through a pullback and almost back at the bottom of its normal trading range. Could be at a reasonable value area. Worth a watch if it heads back up.
$DHRPosition :
Entry price: 234.94
SL: 227.11 (-3.33%)
TP: 258.45 (+8.47%)
R:R: 3.
Fundamentals :
Sector: Medical
EPS % Chg (Last Qtr): 62%
3 Year EPS Growth Rate: 8%
EPS Est % Chg (Current Yr): 36%
Sales % Chg (Last Qtr): 34%
3-Year Sales Growth Rate: 2%
Annual Pre -Tax Margin: 22.5%
Technicals
Flag/Pennant breakout with hammer in the previous session.
DHR FALLFrom a technical point of view, a notable loss of bullish strength is observed as can be seen in the difference between the inclination of the first line and the second. DHR touches resistance and creates a double top pattern.
In addition, on May 29 there was a large movement of insiders.
It is likely to fall, the target would be 150.
DHR formed a cup and handle pattern but needs higher volumeDHR in the daily chart has broken out off a cup and handle pattern. It however lacks enough strong volume to justify the breakout. The volume was actually decreasing in the last trading sessions. Maybe we get more daily bars printing at this breakout level with higher volume.
Danaher DHR at Gap Support Cepheid FDA Approved Coronavirus TestCepheid created a diagnostic test that could detect the novel coronavirus in approximately 45 minutes. This test was just approved by the FDA today. Also, Cepheid was just bought out by Danaher (DHR). This is why I'm doing an analysis for Danaher.
Looking at the DHR stock, we see that it just reached the top of the gap that appeared in February 2019.
If it goes below this gap, then we may see a gap fill which is why it's important to use a tight stop. However, I believe it is more likely, especially given the bullish catalyst, that we see the stock rise.
My first target is right below the trapped longs. Anyone who bought in the red rectangle area, is praying for an exit.
The more aggressive target (target 2) is a return to the top of the trend line.
I realize this analysis is simple, but from my experience, it doesn't need to be more complicated. Check my most recent idea where I predicted the top of SPY to the dollar using a single trend line.
Happy trading!